ENTA - Enanta Pharma GAAP EPS of -$1.79 beats by $0.45 revenue of $17.8M beats by $4.91M May, 10 2023 02:51 PM Enanta Pharmaceuticals Inc. 2023-05-10 14:51:24 ET Enanta Pharma press release ( NASDAQ: ENTA ): Q2 GAAP EPS of -$1.79 beats by $0.45 . Revenue of $17.8M (-4.9% Y/Y) beats by $4.91M . For further details see: Enanta Pharma GAAP EPS of -$1.79 beats by $0.45, revenue of $17.8M beats by $4.91M